Earnings Feed
Start Free
Home/Insiders/Cordova Ashley
CA
SEC Insider//CIK 0001822014

Cordova Ashley

CIK 00018220141 companyWAYNE, PA
SEC Profile

Transactions

50

Companies

1

Filings

11

CIK

0001822014

Recent Transactions

50 trades
  • Purchase
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-09-05$12.22/sh+81,550→ 437,569 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-06-30$15.13/sh+833→ 356,019 total
  • Award
    NovoCure Ltd$NVCR

    Stock Options (Right to buy)

    2025-03-04$18.19/sh+224,123→ 224,123 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-03-04$18.19/sh+151,181→ 355,186 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-03-03$18.54/sh−2,053→ 204,005 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-02-28$18.28/sh−2,341→ 206,058 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-02-28$18.28/sh−2,341→ 206,058 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-02-27$19.92/sh−9,345→ 210,207 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-02-27$20.55/sh−1,808→ 208,399 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-02-27$19.92/sh−9,345→ 210,207 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-02-27$20.55/sh−1,808→ 208,399 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2024-12-31$14.75/sh+373→ 219,552 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2024-08-02$20.14/sh−688→ 219,179 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2024-06-28$12.24/sh+1,286→ 220,465 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2024-02-27$16.30/sh+102,249→ 219,867 total
  • Award
    NovoCure Ltd$NVCR

    Stock Options (Right to buy)

    2024-02-27$16.30/sh+156,348→ 156,348 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-11-02$11.46/sh+175→ 117,618 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Stock Option (Right to Buy)

    2023-11-02−175→ 0 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-10-31$11.46/sh+7,561→ 107,211 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Stock Option (Right to Buy)

    2023-10-31−2,480→ 0 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-10-31$7.15/sh+7,752→ 117,443 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Stock Option (Right to Buy)

    2023-10-31−7,561→ 175 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-10-31$11.44/sh+2,480→ 109,691 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Stock Option (Right to Buy)

    2023-10-31−7,752→ 0 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-09-01$21.82/sh−883→ 99,650 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-08-02$30.25/sh−1,144→ 100,533 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-06-30$35.28/sh+367→ 101,677 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-03$76.16/sh−4,730→ 102,085 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-03$76.16/sh−775→ 101,310 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-03+11,808→ 106,815 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-02$75.28/sh−1,055→ 95,007 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-01$76.36/sh−2,198→ 96,062 total
  • Award
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2023-02-28$76.97/sh+39,614→ 39,614 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-02-28+23,818→ 98,260 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-06$62.30/sh+66→ 74,442 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2022-12-02$7.15/sh−2,000→ 7,752 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-12-02$7.15/sh+2,000→ 74,376 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-09-02$79.04/sh−885→ 72,376 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-08-02$70.20/sh+7,122→ 73,261 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-07-05$59.08/sh+251→ 66,139 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-03-08$70.10/sh−759→ 60,848 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-03-04$70.41/sh−556→ 61,607 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-03-03$74.50/sh−1,149→ 62,163 total
  • Award
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2022-03-03$80.59/sh+37,664→ 37,664 total
  • Award
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2022-03-03$80.59/sh+5,140→ 5,140 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2022-03-03$15.60/sh−3,840→ 0 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-03-03$15.60/sh+3,840→ 64,688 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2022-03-03$11.46/sh−1,200→ 7,736 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-03-03$11.46/sh+1,200→ 65,888 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-03-03+21,508→ 63,312 total

Companies

1

Recent Filings

11

Address

C/O NOVOCURE INC. 1550 LIBERTY RIDGE DRIVE, SUITE 115

WAYNE, PA, 19087

View on SEC.gov